Stay updated on Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial
Sign up to get notified when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.

Latest updates to the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3, reflecting an internal version update that does not alter the study details presented on the page.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision: v3.4.3 applied, replacing v3.4.2. No user-visible changes to the study details page.SummaryDifference0.1%

- Check59 days agoChange DetectedOnly minor UI/version changes are observed: a new 'Revision: v3.4.2' label and removal of the older funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check66 days agoChange DetectedAdded a government funding lapse notice with status updates and links to cc.nih.gov and opm.gov; added release note Revision: v3.4.1; removed the prior release note Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check73 days agoChange DetectedAdded 'Show glossary' and updated footer/status labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', alongside a revision note 'Revision: v3.4.0'. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and prior 'Revision: v3.3.4'.SummaryDifference0.2%

- Check87 days agoChange DetectedRevision: v3.3.4 added and v3.3.3 removed; changes are limited to revision metadata and do not affect study details or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of Nivolumab and Cabiralizumab Clinical Trial page.